Diagnostic Approach to Periodic Fever in Children
For children with recurrent fevers, first establish whether the fever pattern is truly periodic (stereotypical episodes with fever-free intervals), then systematically rule out infections and malignancies before considering autoinflammatory syndromes, with genetic testing reserved for those meeting specific clinical criteria.
Initial Assessment and Fever Pattern Characterization
The diagnostic approach begins by documenting the fever pattern through a meticulous fever diary that records temperature, duration, and associated symptoms 1, 2. This distinguishes true periodic fever from sequential viral infections, which are the most common cause of recurrent fevers in well-appearing children 1, 2.
Key Historical Features to Elicit:
- Fever characteristics: Duration of each episode, fever-free intervals, maximum temperature, and whether episodes are stereotypical (identical pattern each time)
- Age at onset: Onset before age 1 year suggests mevalonate kinase deficiency (MKD) 3
- Episode duration:
- Family history: Autosomal dominant inheritance patterns, ethnic background (Mediterranean/Middle Eastern ancestry increases FMF likelihood) 4
- Triggers: Cold/stress exposure, post-vaccination episodes, physical exertion 3
Physical Examination During Fever Episodes:
For CAPS (Cryopyrin-Associated Periodic Syndromes) 3:
- Urticaria-like rash (non-pruritic)
- Sensorineural hearing loss
- Skeletal abnormalities
- Signs of chronic aseptic meningitis
For TRAPS 3:
- Migratory rash
- Periorbital edema
- Severe myalgia
- Conjunctivitis
For MKD 3:
- Gastrointestinal symptoms (abdominal pain, vomiting, diarrhea)
- Painful cervical lymphadenopathy
- Aphthous stomatitis
- Maculopapular rash
- Aphthous ulcers
- Pharyngitis with exudates
- Cervical adenitis
For DIRA (Deficiency of IL-1 Receptor Antagonist) 3:
- Pustular psoriasis-like rashes
- Nail changes (onychomadesis)
- Bone tenderness
Laboratory Evaluation Algorithm
During Febrile Episodes:
Mandatory initial workup 3:
- C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR): Markedly elevated during attacks, normalize between episodes
- Complete blood count with differential: Look for leukocytosis, anemia of chronic disease
- Serum amyloid A (SAA) if available: More sensitive than CRP for autoinflammatory diseases 3
- S100 proteins if available 3
Additional testing based on clinical suspicion:
- Urinalysis with culture: Rule out urinary tract infection
- Blood cultures: Rule out bacteremia
- Mevalonic acid in urine: If MKD suspected (episodes starting <1 year, post-vaccination triggers) 3
Between Episodes:
- Screening for amyloidosis in patients with longstanding untreated inflammation: Urinary protein, serum creatinine 3
- Immunoglobulin levels and vaccine titers: Rule out immunodeficiency if infection pattern suggests this
Specialized Diagnostic Studies
When to Obtain Imaging:
For CAPS 3:
- Audiogram: Detect sensorineural hearing loss
- Ophthalmologic examination: Assess for uveitis, papilledema
- Head MRI and lumbar puncture: If signs of chronic meningitis (headaches, neurologic symptoms)
For DIRA 3:
- Chest X-ray: Assess for rib flaring
- X-rays of long bones: Look for periostitis, metaphyseal changes
- MRI or CT of spine: Evaluate odontoid process for osteomyelitis
- Skin biopsy: Neutrophilic dermatosis with subcorneal pustules is highly suggestive 3
Genetic Testing Strategy
Indications for genetic testing 4:
- Clinical symptom pattern consistent with specific autoinflammatory syndrome
- Recurrent fevers with elevated inflammatory markers during attacks that normalize between episodes
- Family history of similar symptoms
- Ethnic background associated with specific syndromes
Targeted single-gene testing if clinical phenotype strongly suggests specific syndrome:
- MEFV for FMF (especially Mediterranean/Middle Eastern ancestry)
- MVK for MKD (onset <1 year, post-vaccination triggers)
- TNFRSF1A for TRAPS (long episodes, migratory rash, periorbital edema)
- NLRP3 for CAPS (urticaria-like rash, cold triggers, hearing loss)
- IL1RN for DIRA (pustular rash, osteomyelitis)
Next-generation sequencing (NGS) panel if phenotype is atypical or overlapping 4
Deep sequencing may be needed for CAPS and TRAPS to detect somatic mosaicism not identified by standard NGS 3
Chromosomal microarray analysis (CMA) for suspected DIRA if Sanger sequencing or whole exome sequencing is negative (detects large deletions in IL1RN) 3
Critical Caveats:
- Low penetrance variants (e.g., R121Q in TNFRSF1A, certain NLRP3 variants) may present with atypical features and different treatment responses 3
- Negative genetic testing does not exclude periodic fever syndrome: PFAPA, the most common periodic fever in childhood, has no identified genetic basis 1, 5
- Positive genetic testing requires clinical correlation: Some variants are of uncertain significance
Differential Diagnosis Exclusions
Rule Out First:
Sequential viral infections 1, 2:
- Most common cause of recurrent fevers in well-appearing children
- Episodes are not stereotypical
- Variable fever-free intervals
- Associated with typical viral symptoms (rhinorrhea, cough)
Occult infections 7:
- Urinary tract infection (especially in children <2 years)
- Endocarditis (if cardiac risk factors)
- Occult abscess
Malignancy 2:
- Leukemia, lymphoma
- Consider if: progressive symptoms, weight loss, hepatosplenomegaly, abnormal CBC
Immunodeficiency 1:
- Consider if: severe or unusual infections, failure to thrive, chronic diarrhea
- Check immunoglobulin levels, vaccine titers, HIV testing if risk factors
Kawasaki disease 8:
- Fever >5 days with conjunctival injection, rash, mucositis, extremity changes, lymphadenopathy
- Requires urgent treatment to prevent coronary artery aneurysms
Diagnostic Algorithm Summary
- Document fever pattern with detailed diary (temperature, duration, symptoms, triggers)
- Obtain inflammatory markers during episode: CRP, ESR, CBC
- Rule out infection: Urinalysis, blood cultures, consider viral testing
- If periodic pattern confirmed and infection excluded:
- Match clinical features to specific syndrome criteria
- Obtain syndrome-specific imaging (audiogram for CAPS, skeletal imaging for DIRA)
- Consider genetic testing if clinical criteria met
- If genetic testing negative but clinical suspicion high: Consider PFAPA (most common, no genetic test available) or repeat testing with broader panel
- Screen for complications: Amyloidosis in longstanding untreated cases
Common pitfall: Do not rely on response to antipyretics to rule out serious bacterial infection—this has been shown to be unreliable 9. Similarly, clinical appearance alone is insufficient; 42% of children with bacteremia or meningitis appear well 7.